HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hitoshi Suzuki Selected Research

Apnea

5/2015Impact of sleep-disordered breathing on myocardial damage and metabolism in patients with chronic heart failure.
7/2014Suppressive effects of adaptive servo-ventilation on ventricular premature complexes with attenuation of sympathetic nervous activity in heart failure patients with sleep-disordered breathing.
1/2014Adaptive servo-ventilation therapy improves long-term prognosis in heart failure patients with anemia and sleep-disordered breathing.
9/2012Adaptive servo ventilation improves Cheyne-Stokes respiration, cardiac function, and prognosis in chronic heart failure patients with cardiac resynchronization therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hitoshi Suzuki Research Topics

Disease

67IGA Glomerulonephritis (IGA Nephropathy)
06/2022 - 01/2004
31Proteinuria
06/2022 - 05/2005
27Heart Failure
07/2018 - 01/2002
19Infections
02/2021 - 05/2002
18Hematuria
05/2022 - 01/2004
18Glomerulonephritis
02/2021 - 11/2003
18Nephritis
02/2021 - 01/2002
11Inflammation (Inflammations)
05/2020 - 11/2003
10Cardiovascular Diseases (Cardiovascular Disease)
01/2018 - 01/2014
7Chronic Renal Insufficiency
10/2018 - 11/2011
7Hypertension (High Blood Pressure)
11/2017 - 01/2014
6Disease Progression
04/2022 - 09/2012
6Neoplasms (Cancer)
01/2021 - 04/2003
6Diabetes Mellitus
01/2021 - 10/2015
6Purpura
11/2019 - 08/2004
6Death (Near-Death Experience)
01/2018 - 01/2012
5Obesity
06/2020 - 01/2014
5Vasculitis (Vasculitides)
11/2019 - 03/2007
5Nephrotic Syndrome (Syndrome, Nephrotic)
06/2007 - 12/2002
4Kidney Diseases (Kidney Disease)
02/2021 - 07/2010
4Autoimmune Diseases (Autoimmune Disease)
01/2021 - 05/2015
4Dyslipidemias (Dyslipidemia)
01/2021 - 12/2014
4IgA Vasculitis (Purpura, Schoenlein Henoch)
12/2019 - 01/2007
4Lupus Nephritis
01/2019 - 02/2008
4Liver Diseases (Liver Disease)
01/2018 - 01/2014
4Ventricular Tachycardia
01/2018 - 02/2008
4Fever (Fevers)
07/2015 - 05/2002
4Apnea
05/2015 - 09/2012
4Brain Diseases (Brain Disorder)
04/2009 - 05/2005
4Respiratory Syncytial Virus Infections
11/2008 - 05/2002
3Diabetic Nephropathies (Diabetic Nephropathy)
01/2021 - 06/2018
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2021 - 01/2005
3Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II)
01/2021 - 03/2005
3Chronic Kidney Failure (Chronic Renal Failure)
11/2020 - 08/2011
3Body Weight (Weight, Body)
06/2020 - 12/2004
3Arthritis (Polyarthritis)
01/2020 - 05/2011
3Anemia
10/2018 - 01/2014
3Cicatrix (Scar)
03/2018 - 01/2012
3Myocardial Ischemia (Ischemic Heart Diseases)
12/2016 - 11/2012
3Atrial Fibrillation
11/2016 - 04/2015
3Hyperuricemia
10/2015 - 01/2014
3Hyperlipidemias (Hyperlipidemia)
01/2015 - 06/2007
3Coronary Artery Disease (Coronary Atherosclerosis)
01/2015 - 03/2008
3Rupture
03/2014 - 06/2003

Drug/Important Bio-Agent (IBA)

55Immunoglobulin A (IgA)IBA
06/2022 - 01/2004
28galactosyl-deficient IgA1IBA
06/2022 - 01/2007
23Antigen-Antibody Complex (Immune Complex)IBA
01/2022 - 03/2006
18Galactose (Galactopyranose)FDA LinkGeneric
01/2022 - 01/2007
16Polysaccharides (Glycans)IBA
01/2018 - 01/2007
14Immunoglobulin G (IgG)IBA
01/2022 - 07/2004
11AutoantibodiesIBA
01/2021 - 02/2011
10Biomarkers (Surrogate Marker)IBA
05/2022 - 11/2013
10Proteins (Proteins, Gene)FDA Link
03/2022 - 06/2003
10SteroidsIBA
11/2020 - 12/2002
8Prednisolone (Predate)FDA LinkGeneric
02/2021 - 01/2004
8CytokinesIBA
05/2020 - 05/2002
8mizoribineIBA
08/2007 - 01/2004
7Immunoglobulins (Immunoglobulin)IBA
01/2022 - 04/2007
7MethylprednisoloneFDA LinkGeneric
02/2021 - 04/2003
6AutoantigensIBA
05/2020 - 09/2012
6AntibodiesIBA
01/2019 - 09/2003
6C-Reactive ProteinIBA
01/2018 - 05/2002
5Messenger RNA (mRNA)IBA
04/2022 - 05/2007
5LigandsIBA
01/2021 - 01/2015
5Complement System Proteins (Complement)IBA
01/2020 - 11/2003
5Troponin T (Troponin T1)IBA
05/2015 - 01/2014
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2015 - 05/2002
5Pharmaceutical PreparationsIBA
12/2013 - 10/2006
5Cyclosporine (Ciclosporin)FDA LinkGeneric
04/2008 - 01/2005
4oxidized low density lipoproteinIBA
01/2021 - 06/2007
4InterleukinsIBA
05/2020 - 10/2005
4Uric Acid (Urate)IBA
01/2018 - 01/2012
4Interleukin-6 (Interleukin 6)IBA
11/2017 - 05/2002
4EnzymesIBA
05/2016 - 04/2004
4Peptides (Polypeptides)IBA
01/2016 - 05/2007
3Anti-Bacterial Agents (Antibiotics)IBA
01/2021 - 11/2003
3LDL CholesterolIBA
01/2021 - 06/2018
3Immunosuppressive Agents (Immunosuppressants)IBA
11/2020 - 03/2007
3AntigensIBA
01/2020 - 04/2004
3AcetoneIBA
07/2018 - 10/2017
3CreatinineIBA
06/2018 - 03/2005
3Brain Natriuretic Peptide (Natrecor)FDA Link
01/2018 - 07/2013
3Hemoglobins (Hemoglobin)IBA
10/2017 - 04/2015
3Toll-Like Receptor 9IBA
04/2017 - 12/2008
3DiureticsIBA
10/2015 - 12/2013
3AlbuminsIBA
03/2015 - 09/2003
3human NPPA protein (carperitide)IBA
01/2015 - 12/2013
3TolvaptanFDA Link
01/2015 - 12/2013
3VaccinesIBA
01/2012 - 01/2009
3Ceruloplasmin (Ferroxidase)IBA
12/2007 - 01/2006
3Familial apoceruloplasmin deficiencyIBA
12/2007 - 01/2006

Therapy/Procedure

40Therapeutics
01/2021 - 04/2003
8Drug Therapy (Chemotherapy)
04/2022 - 08/2004
7Tonsillectomy
12/2017 - 11/2006
7Cardiac Resynchronization Therapy
08/2017 - 01/2012
6Patient Readmission
01/2018 - 01/2014
3Ligation
09/2021 - 05/2019
3Blood Component Removal (Apheresis)
01/2021 - 06/2007
3Plasmapheresis
11/2020 - 08/2004
3Defibrillators (Defibrillator)
06/2016 - 02/2008